Just reported
From Resmed's results release of 29 октября 2026 г.; its quarterly report has since been filed.
Actual
1,41B $
+5,9 % y/y
-3,3 % q/q
Guided
—
No guide given
Actual
2,92 $
+23 % y/y
+11 % q/q
Guided
—
No guide given
Actual
453M $
+1,4 % y/y
+1,0 % q/q
Guided
—
No guide given
Full year 2027
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Доли выручки — это оценки за quarter ended 2026-03-31, а не цифры из поданной отчётности.
AirSense 11
A connected machine that delivers continuous or automatically adjusted air pressure to treat sleep apnea.
AirCurve 11
A bilevel breathing machine that provides different pressure levels for breathing in and out, for people needing more support or with complex breathing disorders.
Astral ventilators
Ventilators that provide breathing support, including for people receiving care at home.
AirTouch N30i, AirTouch F30i, and AirFit F40 masks
Masks that connect a person to a breathing machine during sleep; the named models include fabric and silicone designs.
myAir and AirView
Software for patients to engage with their sleep treatment and for providers to connect with and support patients.
Brightree and MEDIFOX DAN
Software products for residential care and home medical equipment providers.
Полная финансовая отчётность →
ResMed makes devices that help people breathe during sleep and ventilators for people who need breathing support. It also sells masks and software for patients, medical equipment providers, and residential care providers. Its sleep products include machines that connect with patient and provider software.
Построено по собственной отчётности Resmed Inc., поданной в Комиссию по ценным бумагам и биржам США (SEC). Цифры — как отчиталась компания, история на акцию пересчитана на сегодняшнюю базу. Это описание бизнеса — не инвестиционная рекомендация и не совет что-либо покупать или продавать.
239,53 $+0,2 %закрытие 13 нояб.
Данные по 30 сентября 2026 г., из отчёта 10-Q, поданного 30 октября 2026 г.
ResMed sells breathing machines and masks for sleep apnea and other breathing disorders to patients through medical equipment providers.
The themes Resmed is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
ISRGIntuitive Surgical, Inc.153,8B $A+
MDLNMedline Inc.51,9B $A
ALCAlcon Inc.36,1B $A
BLCOBausch & Lomb Corp7,5B $A-
ATRCAtriCure, Inc.2,9B $ARose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 окт. 2026 г.CBGraded C, now B
MCKMckesson Corporation4 нояб. 2026 г.BAGraded B, now A
CVSCVS Health Corp4 нояб. 2026 г.BAGraded B, now A
EWEdwards Lifesciences Corporation4 нояб. 2026 г.BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 окт. 2026 г.CAGraded C, now AGrade B+
Полоса под ценой показывает оценку на каждую дату — только по отчётам, которые к тому моменту уже были опубликованы.
Показано 2 из 41 кварталов истории оценок компании Resmed Inc.. Остальные 39 уходят к октябрь 2016 г..
